The pathophysiological role of mitochondrial oxidative stress in lung diseases

Area of Science:

• Pulmonary Medicine
• Mitochondrial Biology
• Oxidative Stress Research

Background:

• Mitochondria are central to reactive oxygen species (ROS)-mediated lung diseases, including fibrosis, asbestos exposure, chronic airway diseases, and lung cancer.
• Mitochondrial DNA (mtDNA) is susceptible to oxidative damage, leading to mitochondrial dysfunction and acting as a damage-associated molecular pattern (DAMP) that triggers inflammation.
• Dysfunctional mitochondria contribute to pathogenesis through impaired electron transport chain function and loss of mitochondrial membrane potential.

Purpose of the Study:

• To review the intricate crosstalk between alveolar epithelial cells, alveolar macrophages, and mitochondria in the context of lung diseases.
• To discuss the roles of ROS-related transcription factors and downstream signaling pathways in these diseases.
• To explore novel therapeutic strategies targeting mitochondrial dysfunction and oxidative stress in lung diseases.

Main Methods:

• Literature review focusing on mitochondrial involvement in ROS-dependent lung diseases.
• Analysis of cellular crosstalk between alveolar epithelial cells and alveolar macrophages concerning mitochondria.
• Examination of ROS-related transcription factors and cell signaling pathways.

Main Results:

• Mitochondrial dysfunction, driven by damaged mtDNA, exacerbates lung inflammation and disease progression.
• Crosstalk between alveolar cells and macrophages, mediated by mitochondria, is a critical component of lung disease pathogenesis.
• Oxidative stress and mitochondrial damage are key drivers of inflammatory and immune responses in the lung.

Conclusions:

• Targeting oxidative stress with antioxidants like thiol molecules, polyphenols, and superoxide dismutase (SOD) is a promising therapeutic avenue.
• Promoting mitochondrial biogenesis may offer a novel strategy for treating lung diseases with limited effective options.
• Interventions aimed at restoring mitochondrial function hold potential for managing debilitating lung conditions.